Mr. James Howard-Tripp reports

STAGEZERO LIFE SCIENCES PARTNERS WITH MY ONE MEDICAL SOURCE AND 1,000+ MEDICAL ACCESS POINTS IN THE USA

Stagezero Life Sciences Ltd. is partnering with My One Medical Source (MOMS) to offer the Stagezero suite of diagnostics and treatment protocols to MOMS's national customer base.

"MOMS has over 1,000 medical access points (MAPS) across the U.S. and connects providers, employers and patients with clinical laboratories. It instantly establishes a national patient service centre network for Stagezero and CareOncology and takes our high-complexity lab and makes it into 50 state local labs with all of the attendant customer base. MOMS will actively promote Stagezero's diagnostic programs," said James Howard-Tripp, chairman and chief executive officer of Stagezero. "Coupled with the CareOncology clinical group providing clinical oversight, and via telehealth, we can cater to all 50 states and actively engage with the MAPS and their customer base, as well as draw in new patients. The new programs we are introducing continue to enhance our visibility," he further added.

Approximately 1.9 million Americans will be diagnosed with cancer this year, with more than half of them diagnosed with late stage cancer. Five-year survival rates for stage 3 and 4 cancer are significantly poorer than if it is diagnosed at stage 1 or 2 (such as colorectal: 90 per cent if found early versus 14 per cent if found late); cost of treating late-stage cancer is also two to four times higher than treating early-stage cancer. It is critical that cancer be diagnosed as early as possible.

The U.S. cancer screening market is $77.4-billion, with a compound annual growth rate of 7 per cent. The economic burden associated with cancer is $150.8-billion. Self-financed health care employers account for approximately 64 per cent of all employers and employ 100 million Americans. Cancer is a key driver of their health care costs.

About Stagezero Life Sciences Ltd.

Stagezero Life Sciences is a vertically integrated health care company dedicated to improving the early detection and management of cancer and other chronic diseases through next-generation diagnostics and unique telehealth programs that provide clinical interventions to assist patients who currently have cancer (COC protocol) as well as help patients reduce the risk of developing late-stage disease (AVRT).

We seek Safe Harbor.